icatibant acetate

Poland

Drugs containing this active substance

  • ICATIBANT MEDICAL VALLEY

    The medicine is intended for the treatment of symptoms of hereditary angioedema (HAE) in adults and in adolescents and children aged 2 years and older.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    icatibant acetate 31.4 mg

    ATC: B06AC02

    Manufacturer: Universal Farma, S.L.

  • The medicine is intended for the treatment of symptoms of hereditary angioedema (HAE) in adults as well as in adolescents and children aged 2 years and older.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    icatibant acetate 31.4 mg

    ATC: B06AC02

    Manufacturer: Universal Farma, S.L.

  • The medicinal product is intended for the treatment of symptoms of hereditary angioedema (HAE) in adults and in adolescents and children aged 2 years and older.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    icatibant acetate 30 31.38-35.52 mg/3.0 ml

    ATC: B06AC02

    Manufacturer: Eurofins Proxy Laboratories B.V. Pharmadox Healthcare Ltd.